Выходит 4 номеров в год
ISSN Печать: 0893-9675
ISSN Онлайн: 2162-6448
Indexed in
Metastasectomy for Stage IV Melanoma in the Era of Effective Systemic Agents
Get access
Краткое описание
There is an increasing body of literature that strongly suggests that complete metastasectomy for stage IV melanoma can improve overall survival. Before 2011, the efficacy of systemic therapy for melanoma was poor, making surgical resection the mainstay for treatment and the only realistic chance for cure. Now, in just a short time span (2011−2014), we have six Food & Drug Administration (FDA)-approved drugs for patients with stage IV metastatic melanoma. In the absence of prospective clinical trials evaluating the most advantageous sequence and timing for systemic therapy and surgical resection in the setting of stage IV melanoma, the treating surgical and medical oncologists must jointly devise individual treatment plans that take into account the advantages and disadvantages of each modality. This multidisciplinary approach gives the patient the best chance for prolonged survival. This article briefly reviews the FDA-approved systemic therapy options, discusses the data for site-specific metastasectomy, critiques the previous stage IV metastasectomy trials, and presents a view for moving forward with a multidisciplinary approach in mind.
-
Sullivan Ryan J., Atkins Michael B., Kirkwood John M., Agarwala Sanjiv S., Clark Joseph I., Ernstoff Marc S., Fecher Leslie, Gajewski Thomas F., Gastman Brian, Lawson David H., Lutzky Jose, McDermott David F., Margolin Kim A., Mehnert Janice M., Pavlick Anna C., Richards Jon M., Rubin Krista M., Sharfman William, Silverstein Steven, Slingluff Craig L., Sondak Vernon K., Tarhini Ahmad A., Thompson John A., Urba Walter J., White Richard L., Whitman Eric D., Hodi F. Stephen, Kaufman Howard L., An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0, Journal for ImmunoTherapy of Cancer, 6, 1, 2018. Crossref
-
Viehof Jan, Livingstone Elisabeth, Loscha Elena, Stockhammer Paul, Bankfalvi Agnes, Plönes Till, Mardanzai Khaled, Zimmer Lisa, Sucker Antje, Schadendorf Dirk, Hegedüs Balazs, Aigner Clemens, Prognostic factors for pulmonary metastasectomy in malignant melanoma: size matters, European Journal of Cardio-Thoracic Surgery, 56, 6, 2019. Crossref
-
Asare Elliot A., Swami Umang, Stewart John H., Landmark Series on Disparities in Surgical Oncology: Melanoma, Annals of Surgical Oncology, 28, 12, 2021. Crossref
-
Abbati Francesca, Altimari Annalisa, Corti Barbara, Dika Emi, Sperandi Francesca, Melotti Barbara, BRAF ‐mutated malignant melanoma with chondrosarcomatous differentiation in inguinal nodal metastasis , Clinical Case Reports, 9, 4, 2021. Crossref